Results 81 to 90 of about 2,155 (206)

Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis

American Journal of Ophthalmology Case Reports, 2020
To report a case of intravitreal methotrexate treatment and fluocinolone acetonide (Retisert®) implantation in a patient with Vogt-Koyanagi-Harada syndrome (VKH).A 34-year-old male was referred for worsening vision and bilateral panuveitis consistent with VKH.
Jong G. Park, Natalia F. Callaway, Cassie A. Ludwig, Vinit B. Mahajan   +3 more
openaire   +3 more sources

A Systematic Review on Clinical Evidence for Topical Metformin: Old Medication With New Application

Health Science Reports, Volume 7, Issue 12, December 2024.
ABSTRACT Background and Aims Metformin is a widely used oral agent for controlling diabetes mellitus, but it also has other therapeutic benefits for various conditions. In addition, conventional oral metformin, and topical metformin have been used in, in‐vitro studies in the treatment of acne, psoriasis, wound healing, and and so forth.
Kimia Afshar, Sara Adibfard, Mohammad Hossein Nikbakht, Fereshte Rastegarnasab, Mahsa Pourmahdi‐Boroujeni, Bahareh Abtahi‐Naeini   +5 more
wiley   +1 more source

Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review

Ophthalmology and Therapy, 2018
Diabetic macular edema (DMO) is a leading cause of blindness in the working age population. Although anti-vascular endothelial growth factor (VEGF) therapy provided a major advance in treatment of DMO for many patients, there is a significant proportion ...
William Fusi-Rubiano, Rebecca R. Blow, Mark Lane, Rupal Morjaria, Alastair K. Denniston   +4 more
doaj   +1 more source

Treatment of Posterior Uveitis With a Fluocinolone Acetonide Implant [PDF]

Archives of Ophthalmology, 2008
To evaluate the safety and efficacy of 0.59-mg and 2.1-mg fluocinolone acetonide (FA) intravitreous implants in noninfectious posterior uveitis.A 3-year, multicenter, randomized, historically controlled trial of the 0.59-mg FA intravitreous implant in 110 patients and the 2.1-mg FA intravitreous implant in 168 patients.Recurrence rate, vision, and ...
David G, Callanan, Glenn J, Jaffe, Daniel F, Martin, P Andrew, Pearson, Timothy L, Comstock   +4 more
openaire   +2 more sources

Cosmeceuticals in photoaging: A review

Skin Research and Technology, Volume 30, Issue 9, September 2024.
Abstract Background Photoaging is a process of the architecture of normal skin damaged by ultraviolet radiation. Topical cosmeceuticals have been used to treat this condition. The authors aimed to understand the mechanism and level of evidence of different commonly used cosmeceuticals used to treat photodamaged skin.
Lisa Kwin Wah Chan, Kar Wai Alvin Lee, Cheuk Hung Lee, Kar Wai Phoebe Lam, Kar Fai Victor Lee, Raymond Wu, Jovian Wan, Shanthala Shivananjappa, Wong Tin Hau Sky, Hosung Choi, Kyu‐Ho Yi   +10 more
wiley   +1 more source

Integrating Computational and Biological Hemodynamic Approaches to Improve Modeling of Atherosclerotic Arteries

Advanced Science, Volume 11, Issue 26, July 10, 2024.
This review describes and critically evaluates computational and biological models of atherosclerosis, focusing on the hemodynamics of occluded coronary arteries. It examines emerging strategies that integrate computational and biological models and explores the advances in imaging, biofabrication, single‐cell omics, and machine learning for model ...
Thao Nhu Anne Marie Vuong, Michael Bartolf‐Kopp, Kristina Andelovic, Tomasz Jungst, Nona Farbehi, Steven G. Wise, Christopher Hayward, Michael Charles Stevens, Jelena Rnjak‐Kovacina   +8 more
wiley   +1 more source

Scleral melt following Retisert intravitreal fluocinolone implant

Drug Design, Development and Therapy, 2014
Ilias Georgalas,1 Chrysanthi Koutsandrea,1 Dimitrios Papaconstantinou,1 Dimitrios Mpouritis,1 Petros Petrou1,2 1Ophthalmology Department, University of Athens, Athens, Greece; 2Moorfields Eye Hospital, London, UKAbstract: Intravitreal fluocinolone ...
Georgalas I, Koutsandrea C, Papaconstantinou D, Mpouritis D, Petrou P   +4 more
doaj  

Drug Delivery Innovation during Cataract Surgery: Are We Ready for Dropless Cataract Surgery?

Delhi Journal of Ophthalmology, 2019
At present, drug administration options during cataract surgery include topical application. Subconjunctival application is not used now. Intracameral Injection is reserved for antibiotic supplement.
Suresh K. Pandey, Vidushi Sharma
doaj   +1 more source

Cost‐Effectiveness of Topical Prophylaxis Against Tympanostomy Tube Otorrhea: An Economic Decision Analysis

OTO Open, Volume 8, Issue 3, July–September 2024.
Abstract Objective To evaluate the cost‐effectiveness of various topical prophylaxis strategies against posttympanostomy otorrhea using a break‐even analysis. Study Design An economic decision analysis of data collected from purchasing records and the literature. Setting An academic center.
Grant Conner, Yuki Yoshiyasu, Nicholas Rossi, Brian McKinnon   +3 more
wiley   +1 more source

Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema [Corrigendum]

Drug Design, Development and Therapy, 2016
Liu QY, He MM, Shi H, et al. Drug Des Devel Ther. 2015;9: 2527–2535. In “Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials” published ...
Liu QY, He MM, Shi H, Wang QY, Du YR, Liu JL, Ren CD, Xu D, Yu J   +8 more
doaj